From: miRNA-23b as a biomarker of culture-positive neonatal sepsis
EOS/LOS (n = 27, 21) | Full-term patients | Premature patients | p | |||||
---|---|---|---|---|---|---|---|---|
Co/NH (control) (9, 6) | SP/PH (7, 12) | DP/PH (2, 1) | DP/NH (0, 2) | Co/NH (control) (4, 0) | SP/PH (2, 0) | DP/PH (3, 0) | ||
Gender (M/F) | ||||||||
EOS | 5/4 | 4/3 | 1/1 | – | 1/3 | 1/1 | 2/1 | NS |
LOS | 6/0 | 6/6 | 0/1 | 2/0 | – | – | – | NS |
Weight (kg) | ||||||||
EOS | 2.87 ± 0.76 | 3.16 ± 0.65 | 3.30 ± 0.14 | – | 2.01 ± 0.09 | 1.43 ± 0.23 | 1.63 ± 0.57 | < 0.001 |
LOS | 3.17 ± 0.86 | 3 ± 0.86 | 2.5 ± 0 | 2.9 ± 0.28 | – | – | – | < 0.001 |
T (° C) | ||||||||
EOS | 36.17 ± 1.43 | 35.05 ± 1.42 | 34.5 ± 1.27 | – | 36.35 ± 2.30 | 33.07 ± 2.21 | 36.17 ± 1.20 | NS |
LOS | 37.33 ± 2.85 | 38.3 ± 1.53 | 37.4 ± 0 | 39.05 ± 0.95 | – | – | – | NS |
HR (BPM) | – | |||||||
EOS | 136 ± 16.37 | 143.6 ± 17.87 | 125 ± 9.9 | – | 120.5 ± 19.58 | 125 ± 7.07 | 150 ± 10 | NS |
LOS | 151.8 ± 27 | 140.3 ± 17.27 | 180 ± 0 | 135 ± 7.07 | – | – | – | NS |
RR (BrPM) | – | |||||||
EOS | 55.3 ± 14.56 | 55.7 ± 17.1 | 38 ± 5.66 | 58 ± 5.42 | 42 ± 2.83 | 62.67 ± 4.72 | NS | |
LOS | 50.7 ± 14.01 | 52.5 ± 6.1 | 52 ± 0 | 42 ± 2.83 | – | – | – | NS |
Gly (mg/dL) | ||||||||
EOS | 0.95 ± 0.48 | 0.63 ± 0.23 | 0.52 ± 0.60 | 0.73 ± 0.25 | – | 0.45 ± 0.15 | NS | |
LOS | 1.12 ± 0.22 | 0.65 ± 0.21 | – | 0.66 ± 0.17 | – | – | – | NS |
CRP (mg/dL) | ||||||||
EOS | 25.78 ± 17.87 | 41.17 ± 30.75 | – | – | 63 ± 88.25 | – | – | < 0.0001 |
LOS | 47 ± 81.37 | 39.87 ± 29.78 | – | 42 ± 25.45 | – | – | – | NS |
VD vs. CD | – | – | ||||||
EOS | 5/4 | 5/2 | 1/1 | – | 2/2 | 1/1 | 1/2 | NS |
LOS | 5/1 | 1/1 | 1/0 | 2/0 | – | – | – | NS |